PQQ for Cognitive and Negative Symptoms
The Efficacy and Safety of Pyrroloquinoline Quinone add-on Treatment for Negative and Cognitive Symptoms in Chronic Schizophrenia
This study isn't recruiting yet.
Location not clearly listed
Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
The Efficacy and Safety of Pyrroloquinoline Quinone add-on Treatment for Negative and Cognitive Symptoms in Chronic Schizophrenia
This study isn't recruiting yet.
Location not clearly listedPrecision HD-tACS-Based Therapy for the Qualitative and Phenomenological Enhancement of Sensory Experiences in Schizophrenia
This study isn't recruiting yet.
Location not clearly listedEffects of Relapse Management Group Psychoeducation Program Applied to Schizophrenia Patients on Relapse Management and Functional Recovery
This study isn't recruiting yet.
Location not clearly listedThe Effect of Acceptance and Commitment Therapy (ACT)-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychological Flexibility in Individuals With Schizophrenia: A Randomized Controlled Trial
This study isn't recruiting yet.
Location not clearly listedThe Effectiveness of Combining AR/VR Technology in Virtual Clinical Auditory Hallucinations on the Comprehensive Auditory Hallucination Nursing Competency of Psychiatric Nurses
This study isn't recruiting yet.
Multiple locations, including Hualien CityDevelopment and Validation of an Early Prediction Model for Schizophrenia Integrating Transcranial Sonography Structural Imaging and Machine Learning
This study isn't recruiting yet.
In TaizhouThe Efficacy of Combined HD-tDCS and iTBS in Treating Negative Symptoms of Schizophrenia
This study is by invitation only.
In TaipeiLong-term, Safety Extension Study of OLZ/SAM in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
This study is by invitation only.
Multiple locations, including DothanA Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation and Recovery Centers
This study assesses thinking abilities.
This study isn't recruiting yet.
In La JollaThis study isn't recruiting yet.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including BrestWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.